Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH

ClinicalTrials.gov ID: NCT01966614

Public ClinicalTrials.gov record NCT01966614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of a Single Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (The PLUS 1 Trial)

Study identification

NCT ID
NCT01966614
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sophiris Bio Corp
Industry
Enrollment
479 participants

Conditions and interventions

Interventions

  • PRX302 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2013
Primary completion
Nov 30, 2015
Completion
Nov 30, 2015
Last update posted
Apr 26, 2017

2013 – 2015

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801
Not listed Anchorage Alaska 99503
Not listed Laguna Hills California 92653
Not listed Long Beach California 90806
Not listed Los Angeles California 90017
Not listed Newport Beach California 92660
Not listed San Diego California 92120
Not listed San Diego California 92123
Not listed Tarzana California 91356
Not listed Denver Colorado 80220
Not listed Middlebury Connecticut 06762
Not listed Aventura Florida 33180
Not listed Coral Gables Florida 33134
Not listed Pompano Beach Florida 33060
Not listed St. Petersburg Florida 33770
Not listed Wellington Florida 33449
Not listed Coeur d'Alene Idaho 83814
Not listed Meridian Idaho 83642
Not listed Springfield Illinois 62701
Not listed Jeffersonville Indiana 47130
Not listed West Des Moines Iowa 50266
Not listed Baltimore Maryland 21204
Not listed Baltimore Maryland 21237
Not listed Greenbelt Maryland 20770
Not listed Towson Maryland 21204
Not listed Brookline Massachusetts 02445
Not listed Missoula Montana 59808
Not listed Mount Laurel New Jersey 08054
Not listed Albuquerque New Mexico 87109
Not listed Garden City New York 11530
Not listed New York New York 10016
Not listed Newburgh New York 12550
Not listed Poughkeepsie New York 12601
Not listed The Bronx New York 10457
Not listed Concord North Carolina 28025
Not listed Raleigh North Carolina 27612
Not listed Bala-Cynwyd Pennsylvania 19004
Not listed Bryn Mawr Pennsylvania 19010
Not listed Greer South Carolina 29650
Not listed Myrtle Beach South Carolina 29572
Not listed Carrollton Texas 75010
Not listed Dallas Texas 75390
Not listed Houston Texas 77030
Not listed Salt Lake City Utah 84124
Not listed Burien Washington 98166

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01966614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01966614 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →